No effectiveness of anticoagulants for thromboprophylaxis after non-major knee arthroscopy: a systemic review and meta-analysis of randomized controlled trials
Arthroscopic knee surgery is the most commonly performed orthopedic procedure worldwide and whether thromboprophylaxis should be undertaken after knee arthroscopy is still controversial. To evaluate the efficacy of thromboprophylaxis for deep venous thrombosis (DVT) and venous thromboembolism (VTE) after knee arthroscopic surgery. A meta-analysis was conducted using data from eight randomized trials (4148 patients) to compare thromboprophylaxis with placebo or no prophylactic treatment in patients undergoing knee arthroscopy. The benefits and harms of thromboprophylaxis were evaluated, including the incidence of asymptomatic DVT, symptomatic VTE, pulmonary embolism and anti-coagulation related adverse events. Thromboprophylaxis significantly decreased the incidence of DVT (95% CI 0.07–0.64, P = 0.006) and symptomatic VTE in patients undergoing knee arthroscopy (95% CI 0.23–0.76, P = 0.004), but not significantly decreased the incidence of pulmonary embolism (n.s.). Regarding to non-major knee arthroscopy surgery (simple surgical procedures without ligament reconstruction), no significant difference of the incidence of DVT or symptomatic VTE was noted between thromboprophylactic group and control group (n.s.). Thromboprophylactic treatment showed higher incidence rate of anti-coagulation related adverse events compared with the control group (95% CI 1.12–1.90, P = 0.005). There was no significant difference of the incidence of clinically relevant major bleeding between the two groups (n.s.). This meta-analysis indicates no effectiveness of thromboprophylaxis for preventing DVT or symptomatic VTE in patients undergoing non-major knee arthroscopy. Regarding to patient undergoing knee ligament construction, the thromboprophylactic strategy should mainly take into account the patient’s risk factors.
KeywordsVenous Thromboembolism Thrombosis Knee arthroscopy Thromboprophylaxis
We thank all the anonymous reviewers for their helpful suggestions on the quality improvement of our paper.
HXL and GZ was responsible for the study concept and design and drafting of the manuscript. PS and QT was responsible for the trials selection and appraisal of methodological quality. QT and GZ participated in acquisition, analysis, and interpretation of data. XYP provided consultation of statistics and methodology. HXL were in charge of the study concept and design, supervised the study and critically revised the manuscript for important intellectual content. All authors read and approve the final manuscript.
This study was supported by National Natural Science Foundation of China (Nos. 81501869, 81601983).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 9.Canata GL, Chiey A (2003) Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. Presented at the International Society of Arthroscopy, Knee Surgery and Orthopedic Sports Medicine Congress, Auckland, New Zealand, 10–13 March 2003Google Scholar
- 13.Falck-Ytter Y, Francis CW, Johanson NA et al (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guide lines. Chest 141(2 Suppl):e278S–e325SGoogle Scholar
- 15.Haas S (2000) Deep vein thrombosis: beyond the operating table. Orthopedics 23(Suppl):S629–S632Google Scholar
- 19.Kaye ID, Patel DN, Strauss EJ et al (2015) Prevention of venous thromboembolism after arthroscopic knee surgery in a low-risk population with the use of aspirin. Bull Hosp Jt Dis 73(4):243–248Google Scholar